Cargando…
Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions
BACKGROUND: Psychiatric medications are widely prescribed in the USA. Many antipsychotics cause serum hyperprolactinemia as an adverse side effect; prolactin-Janus kinase 2 (JAK2)-signal transducer and activator of transcription 5 (STAT5) signaling both induces cell differentiation and suppresses ap...
Autores principales: | Johnston, A. N., Bu, W., Hein, S., Garcia, S., Camacho, L., Xue, L., Qin, L., Nagi, C., Hilsenbeck, S. G., Kapali, J., Podsypanina, K., Nangia, J., Li, Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960176/ https://www.ncbi.nlm.nih.gov/pubmed/29778097 http://dx.doi.org/10.1186/s13058-018-0969-z |
Ejemplares similares
-
Hyperprolactinemia with Antipsychotic Drugs in Children and Adolescents
por: Rosenbloom, Arlan L.
Publicado: (2010) -
Management of antipsychotic-induced hyperprolactinemia
por: Tewksbury, Ashley, et al.
Publicado: (2016) -
Correction: Hyperprolactinemia with antipsychotic drugs in children and adolescents
por: Rosenbloom, Arlan L
Publicado: (2013) -
Hormonal alterations due to antipsychotic-related hyperprolactinemia
por: Montejo, A.L., et al.
Publicado: (2022) -
Antipsychotics-induced hyperprolactinemia and screening for macroprolactin
por: Ruljancic, Nedjeljka, et al.
Publicado: (2020)